September 30, 2016 3:12 PM ET


Company Overview of Manhattan Pharmaceuticals, Inc.

Company Overview

As of December 29, 2011, Manhattan Pharmaceuticals Inc. was acquired by TG Therapeutics, Inc., in a reverse merger transaction. Manhattan Pharmaceuticals, Inc., a specialty healthcare product company, focuses on developing and commercializing treatments for underserved patient populations. Its portfolio of product candidates includes AST-726, a nasally delivered form of hydroxocobalamin for the treatment of vitamin B12 deficiency; AST-915, an oral treatment for essential tremor; Hedrin, a non-insecticide treatment for pediculosis (head lice); and a topical GEL for the treatment of mild psoriasis. The company has a joint venture agreement with Nordic Biotech Advisors ApS to develop and commer...

48 Wall Street

Suite 1100

New York, NY 10005

United States

Founded in 2001

2 Employees





Key Executives for Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Manhattan Pharmaceuticals, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at